Aim Immunotech Inc Stock Ownership - Who owns Aim Immunotech?

Insider buying vs selling

Have Aim Immunotech Inc insiders been buying or selling?
Nancy BryanDirector2024-03-2138,462$0.39
Stewart AppelrouthDirector2024-03-1590,910$0.33
Thomas K. EquelsCEO President2024-03-1575,758$0.33
Peter W. Rodino IiiCOO Secretary Gen. Counsel2024-03-1537,879$0.33
Thomas K. EquelsCEO President2023-11-2733,861$0.44
Thomas K. EquelsCEO President2023-09-2922,676$0.44
Thomas K. EquelsCEO President2023-08-258,222$0.67
Thomas K. EquelsCEO President2023-08-2414,993$0.67
Thomas K. EquelsCEO President2023-07-1716,950$0.59

1 of 1

AIM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AIM insiders and whales buy or sell their stock.

AIM Shareholders

What type of owners hold Aim Immunotech Inc stock?
William A. Carter4.24%2,116,170$1.18MInsider
Vanguard Group Inc3.99%1,988,704$1.11MInstitution
Thomas K. Equels1.46%729,455$407.04kInsider
Blackrock Inc1.42%707,806$394.96kInstitution
Iraj Eqhbal Kiani1.26%630,886$352.03kInsider
Geode Capital Management LLC0.70%351,657$196.22kInstitution
Stewart Appelrouth0.48%239,765$133.79kInsider
Steven D. Spence0.42%209,410$116.85kInsider
Russel J. Lander0.42%207,983$116.05kInsider
Renaissance Technologies LLC0.40%202,008$112.72kInstitution

1 of 3

AIM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AIM8.32%9.92%Net BuyingNet Buying
SPRB63.59%36.41%Net SellingNet Selling
ACXP6.93%15.26%Net BuyingNet Buying

Aim Immunotech Stock Ownership FAQ

Who owns Aim Immunotech?

Aim Immunotech (NYSEMKT: AIM) is owned by 8.32% institutional shareholders, 9.92% Aim Immunotech insiders, and 81.75% retail investors. William A. Carter is the largest individual Aim Immunotech shareholder, owning 2.12M shares representing 4.24% of the company. William A. Carter's Aim Immunotech shares are currently valued at $1.30M.

If you're new to stock investing, here's how to buy Aim Immunotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.